In a collaborative effort at between the Department of Radiology and the Molecular Imaging and Translational Research Program, Yong Bradley, MD, Associate Professor, and Dustin Osborne, PhD, Assistant Professor, worked jointly to have the University of Tennessee Graduate School of Medicine accepted as part of the Society of Nuclear Medicine Clinical Trials Network. This network matches pharmaceutical companies with institutions to perform new clinical trials. Acceptance into this network is based on imaging capabilities for clinical trials work as well as quantitative scanner validation using a custom phantom for lung lesion simulation. The Biograph mCT, the flagship PET/CT imaging system for The University of Tennessee Medical Center Cancer Institute, has been validated for inclusion in this network as well as the Biograph 16 in the Department of Radiology.
Dr. Osborne said, "Being a part of the clinical trials network will potentially attract new clinical trials work both from the SNM network directly and by providing our hospital-based clinical trials team with additional materials to market our university and hospital to pharmaceutical companies. More importantly, being part of this network opens new doors for the University of Tennessee to be more directly engaged with the Society of Nuclear Medicine."
July 24, 2013
The University of Tennessee Graduate School of Medicine
1924 Alcoa Highway
Knoxville, Tennessee 37920 | 865-305-9290
Copyright © 2017